Citing safety risks, FDA said that products containing cannabidiol (CBD) call for greater supervision than the agency can now offer, and FDA will request new authorities to do so from Congress.

New data from the Substance Abuse and Mental Health Services Administration (SAMHSA) reveal how people living in America reported their experiences with mental health conditions, substance use, and the pursuit of treatment in 2021.

Findings from a new clinical trial found that OTC aspirin can be just as effective as an injectable blood thinner, low-molecular-weight heparin to prevent life-threatening blood clots for patients hospitalized with fractures.

A new CDC report finds that low vaccination uptake for the COVID-19 bivalent vaccine was due to lack of awareness about eligibility status as well as overconfidence in immunity against the virus.

Findings from a new study published in NEJM suggest that pharmacists can safely and effectively start patients with opioid use disorder on buprenorphine.